What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Fibonacci Retracements

Score

-0.6

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 19 20.5 0.21% 0.27% 103.8% -6.1% 323.8%
SHORT 20 19.4 0.35% 0.44% 4.4% -6.8% -77.3%

Summary

Technical Analysis

Opthea (OPT.AX)


Indicator:

FIBONACCI RETRACTION


Signal Strength: MEDIUM
Recommendation:

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading position.


Opthea (ASX:OPT) : The current Fibonacci Retraction levels are:
(23.61%) $2.8
(38.2%) $2.93
(50%) $3.04
(61.8%) $3.15

The current support levels are:
(78.6%) $3.3
(100%) $3.5
(138.2%) $3.85
(161.8%) $4.07
(261.8%) $4.99
(423.61%) $6.48



A Fibonacci retracement is a term used in technical analysis that refers to areas of support (price stops going lower) or resistance (price stops going higher). Fibonacci retracement levels use horizontal lines to indicate areas of support or resistance at the key Fibonacci levels before the trend continues in the original direction.

Calculation: Fibonacci Retracements:
1) Uptrend: C = B — (B — A) x N%;
2) Downtrend: C = B + (A — B) x N%;
3) Fibonacci Levels:
a) 23.61%;
b) 38.2%;
c) 50%;
d) 61.8%;
e) 78.6%;
f) 100%,


PROFILE: Opthea (OPT.AX)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Fibonacci Retracements

Download
Company Close Change(%) Volume Value Signal
DNA Donaco International 0.09 16 3,273,494 0 BEARISH
AFL ASX 50 0.15 7.1 24,671 -0.02 BEARISH
BKY Berkeley Resources 0.25 6.5 1,484 -0.04 BEARISH
ONE Oneview Healthcare 0.18 5.9 24,110 -0.04 BEARISH
CDV Cardinal Resources 0.31 5.1 66,456 -0.04 BEARISH
SIV Silver Chef 0.63 5 9,531 -0.01 BEARISH
RFG Retail Food 0.1 4.3 45,734,174 -0.02 BEARISH
AYS Amaysim Australia 0.39 4 98,562 -0.02 BEARISH
EVO Evolve Education 0.15 3.4 2,579,553 -0.01 BEARISH
PNR Pacific Niugini Minerals 0.15 3.4 427,727 -0.01 BEARISH